[Amlodipine better than atenolol in hypertension. More efficient prevention of the mortality and cardiovascular events according to the ASCOT trial].
Nilsson
Peter M
PM
Universitetssjukhuset MAS, Malmö. Peter.Nilsson@med.lu.se
Håkansson
Jan
J
D017311:Amlodipine / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000191:economics / Q000627:therapeutic use*; D001262:Atenolol / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D016527:Drug Costs; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D012307:Risk Factors
D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D017311:Amlodipine; D001262:Atenolol